The Chemokine SDF-1/CXCL12 Binds to and Signals through the Orphan Receptor RDC1 in T Lymphocytes, Journal of Biological Chemistry, vol.73, issue.42, pp.35760-35766, 2005. ,
DOI : 10.1158/0008-5472.CAN-04-2822
The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry, Nature, vol.382, issue.6594, pp.829-833 ,
DOI : 10.1038/382829a0
Hypoxia Modifies the Transcriptome of Primary Human Monocytes: Modulation of Novel Immune-Related Genes and Identification Of CC-Chemokine Ligand 20 as a New Hypoxia-Inducible Gene, The Journal of Immunology, vol.177, issue.3, pp.1941-1955, 2006. ,
DOI : 10.4049/jimmunol.177.3.1941
NPY Regulates Catecholamine Secretion from Human Adrenal Chromaffin Cells, The Journal of Clinical Endocrinology & Metabolism, vol.86, issue.12, pp.5956-5963, 2001. ,
DOI : 10.1210/jcem.86.12.8091
URL : https://academic.oup.com/jcem/article-pdf/86/12/5956/9170222/jcem5956.pdf
The diagnosis and management of malignant phaeochromocytoma and paraganglioma, Endocrine Related Cancer, vol.14, issue.3, pp.569-585 ,
DOI : 10.1677/ERC-07-0074
URL : http://erc.endocrinology-journals.org/content/14/3/569.full.pdf
, , 2007.
, Neuropeptide Y expression in phaeochromocytomas: relative absence in tumours from patients with von Hippel?Lindau syndrome, Journal of Endocrinology, vol.193, pp.225-233
Endogenous Ligands of PACAP/VIP Receptors in the Autocrine???Paracrine Regulation of the Adrenal Gland, International Reviews of Cytology, vol.249, pp.1-51, 2006. ,
DOI : 10.1016/S0074-7696(06)49001-X
Malignant pheochromocytoma: current status and initiatives for future progress, Endocrine Related Cancer, vol.11, issue.3, pp.423-436, 2004. ,
DOI : 10.1677/erc.1.00829
, Endocrinology, vol.138, issue.12, pp.5256-5265, 1997.
DOI : 10.1210/endo.138.12.5557
Role of PACAP in the physiology and pathology of the sympathoadrenal system, Frontiers in Neuroendocrinology, vol.29, issue.1, pp.128-141, 2008. ,
DOI : 10.1016/j.yfrne.2007.10.001
RECENT ADVANCES IN THE GENETICS OF PHAEOCHROMOCYTOMA AND FUNCTIONAL PARAGANGLIOMA, Clinical and Experimental Pharmacology and Physiology, vol.63, issue.4, pp.376-379, 2008. ,
DOI : 10.1038/sj.onc.1209594
Neuropeptide Y and neuron-specific enolase levels in benign and malignant pheochromocytomas, Neuropeptide Y and neuronspecific enolase levels in benign and malignant pheochromocytomas, pp.1833-1835, 1990. ,
DOI : 10.1002/1097-0142(19901015)66:8<1833::AID-CNCR2820660831>3.0.CO;2-9
Disappearance rate of catecholamines, total metanephrines, and neuropeptide Y from the plasma of patients after resection of pheochromocytoma, Clinical Chemistry, vol.47, pp.1075-1082, 2001. ,
Microarray and Suppression Subtractive Hybridization Analyses of Gene Expression in Pheochromocytoma Cells Reveal Pleiotropic Effects of Pituitary Adenylate Cyclase-Activating Polypeptide on Cell Proliferation, Survival, and Adhesion, Endocrinology, vol.144, issue.6, pp.2368-2379, 2003. ,
DOI : 10.1210/en.2002-0106
PACAP and NGF regulate common and distinct traits of the sympathoadrenal lineage: effects on electrical properties, gene markers and transcription factors in differentiating PC12 cells, European Journal of Neuroscience, vol.93, issue.Suppl. 3, pp.71-82, 2003. ,
DOI : 10.1016/S0306-4522(99)00108-6
Involvement of multiple signaling pathways in PACAP-induced EM66 secretion from chromaffin cells, Regulatory Peptides, vol.137, issue.1-2, pp.79-88, 2006. ,
DOI : 10.1016/j.regpep.2006.04.023
URL : https://hal.archives-ouvertes.fr/hal-01706412
Neuropeptide Y functions as a neuroproliferative factor, Nature, vol.127, issue.6831, pp.940-944, 2001. ,
DOI : 10.1210/endo-127-1-133
SDH5, a Gene Required for Flavination of Succinate Dehydrogenase, Is Mutated in Paraganglioma, Science, vol.48, issue.3, pp.1139-1142, 2009. ,
DOI : 10.1002/1531-8249(200009)48:3<330::AID-ANA7>3.0.CO;2-A
Neuropeptide Y expression distinguishes malignant from benign pheochromocytoma., Journal of Clinical Oncology, vol.7, issue.11, pp.1720-1725, 1989. ,
DOI : 10.1200/JCO.1989.7.11.1720
Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma, FEBS Letters, vol.14, issue.1, pp.6-10, 1994. ,
DOI : 10.1016/0306-4522(85)90156-3
Adrenomedullin antagonist suppresses in vivo growth of human pancreatic cancer cells in SCID mice by suppressing angiogenesis, Oncogene, vol.22, issue.8, pp.1238-1242, 2003. ,
DOI : 10.1038/35025215
Expression of mRNA for PACAP and its receptors in intra- and extra-adrenal human pheochromocytomas and their relationship to catecholamine synthesis, Regulatory Peptides, vol.110, issue.3, pp.213-217, 2003. ,
DOI : 10.1016/S0167-0115(02)00209-4
Targeting adrenomedullin receptors with systemic delivery of neutralizing antibodies inhibits tumor angiogenesis and suppresses growth of human tumor xenografts in mice, The FASEB Journal, vol.23, issue.10, pp.3424-3435, 2009. ,
DOI : 10.1016/S0301-472X(02)00890-1
URL : https://hal.archives-ouvertes.fr/hal-01848088
Identification of an Orphan Receptor Gene as a Type 1 Calcitonin Gene-Related Peptide Receptor, Biochemical and Biophysical Research Communications, vol.217, issue.3, pp.832-838, 1995. ,
DOI : 10.1006/bbrc.1995.2847
Adrenomedullin: A Novel Hypotensive Peptide Isolated from Human Pheochromocytoma, Biochemical and Biophysical Research Communications, vol.192, issue.2, pp.553-560, 1993. ,
DOI : 10.1006/bbrc.1993.1451
Differential Effects of Neuropeptide Y on the Growth and Vascularization of Neural Crest???Derived Tumors, Cancer Research, vol.65, issue.5, pp.1719-1728, 2005. ,
DOI : 10.1158/0008-5472.CAN-04-2192
High Expression of Neuropeptide Y Receptors in Tumors of the Human Adrenal Gland and Extra-Adrenal Paraganglia, Clinical Cancer Research, vol.10, issue.24, pp.8426-8433, 2004. ,
DOI : 10.1158/1078-0432.CCR-04-0821
Coordinated Up-regulation by Hypoxia of Adrenomedullin and One of Its Putative Receptors (RDC-1) in Cells of the Rat Blood-Brain Barrier, Journal of Biological Chemistry, vol.119, issue.51, pp.39914-39919, 2000. ,
DOI : 10.1111/j.1476-5381.1996.tb16050.x
Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles, Journal of Clinical Investigation, vol.111, issue.12, pp.1853-1862, 2003. ,
DOI : 10.1172/JCI16929
Phaeochromocytoma, The Lancet, vol.366, issue.9486, pp.665-675, 2005. ,
DOI : 10.1016/S0140-6736(05)67139-5
, Vascular gene expression in nonneoplastic and malignant brain. American Journal of Pathology, vol.165, pp.601-608, 2004.
Nestin, PDGFR-??, CXCL12 and VEGF in gliomapatients: Different profiles of (Pro-Angiogenic) molecule expression are related with tumor grade and may provide prognostic information, Cancer Biology & Therapy, vol.6, issue.7, pp.1018-1024, 2007. ,
DOI : 10.4161/cbt.6.7.4362
Diagnosis and management of pheochromocytoma ??? recent advances and current concepts, Kidney International, vol.70, pp.30-35, 2006. ,
DOI : 10.1038/sj.ki.5001974
Distribution, functional role, and signaling mechanism of adrenomedullin receptors in the rat adrenal gland, Peptides, vol.20, issue.12, pp.1479-1487, 1999. ,
DOI : 10.1016/S0196-9781(99)00159-X
RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor, Nature, vol.141, issue.6683, pp.333-339, 1998. ,
DOI : 10.1084/jem.183.6.2437
CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature, Proceedings of the National Academy of Sciences, vol.100, issue.20, pp.15735-15740, 2007. ,
DOI : 10.1073/pnas.1933744100
Specific adhesion between pheochromocytoma (PC12) cells and adrenal medullary endothelial cells in co-culture, Cell and Tissue Research, vol.256, issue.2, pp.365-372, 1989. ,
DOI : 10.1007/BF00218894
Localization and characterization of evolutionarily conserved chromogranin A-derived peptides in the rat and human pituitary and adrenal glands, Cell and Tissue Research, vol.310, issue.2, pp.223-236, 2002. ,
DOI : 10.1007/s00441-002-0625-9
URL : https://hal.archives-ouvertes.fr/hal-01706424
Adrenomedullin in the Kidney-Renal Physiological and Pathophysiological Roles, Current Medicinal Chemistry, vol.14, issue.15, pp.1689-1699, 2007. ,
DOI : 10.2174/092986707780830943
Mitogenic actions of neuropeptide Y in vascular smooth muscle cells: synergetic interactions with the ??-adrenergic system, Canadian Journal of Physiology and Pharmacology, vol.83, issue.2, pp.177-185, 2003. ,
DOI : 10.1161/01.RES.83.2.187
Nonclassic Endogenous Novel Regulators of Angiogenesis, Pharmacological Reviews, vol.59, issue.2, pp.185-205, 2007. ,
DOI : 10.1124/pr.59.2.3
URL : http://pharmrev.aspetjournals.org/content/pharmrev/59/2/185.full.pdf
Expression of adrenomedullin and peptide amidation activity in human prostate cancer and in human prostate cancer cell lines, Cancer Research, vol.61, pp.1196-1206, 2001. ,
URL : https://hal.archives-ouvertes.fr/hal-01710707
Regulation of catecholamine release and tyrosine hydroxylase in human adrenal chromaffin cells by interleukin-1??: role of neuropeptide Y and nitric oxide, Journal of Neurochemistry, vol.44, issue.Suppl, pp.911-922, 2009. ,
DOI : 10.1161/01.RES.84.5.587
Production, characterization, and expression of neuropeptide Y by human pheochromocytoma., Journal of Clinical Investigation, vol.96, issue.5, pp.2503-2509, 1995. ,
DOI : 10.1172/JCI118310
, , 1998.
, Peptidergic activation of transcription and secretion in chromaffin cells Cis and trans signaling determinants of pituitary adenylyl cyclase-activating polypeptide (PACAP), Journal of Clinical Investigation, vol.101, pp.863-876
Identification of Potential Gene Markers and Insights into the Pathophysiology of Pheochromocytoma Malignancy, The Journal of Clinical Endocrinology & Metabolism, vol.92, issue.12, pp.4865-4872, 2007. ,
DOI : 10.1210/jc.2007-1253
URL : https://hal.archives-ouvertes.fr/hal-01706427
Clinical aspects of SDHx-related pheochromocytoma and paraganglioma, Endocrine Related Cancer, vol.16, issue.2, pp.391-400, 2009. ,
DOI : 10.1677/ERC-08-0284
Pituitary Adenylate Cyclase-Activating Polypeptide Stimulates Secretoneurin Release and Secretogranin II Gene Transcription in Bovine Adrenochromaffin Cells through Multiple Signaling Pathways and Increased Binding of Pre-Existing Activator Protein-1-Like Transcription Factors, Molecular Pharmacology, vol.60, issue.1, pp.42-52, 2001. ,
DOI : 10.1124/mol.60.1.42
Adrenomedullin is anti-apoptotic in osteoblasts through CGRP1 receptors and MEK-ERK pathway, Journal of Cellular Physiology, vol.15, issue.1, pp.122-128, 2008. ,
DOI : 10.4049/jimmunol.176.9.5548
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes, Genome Biology, vol.3, p.34, 2002. ,
Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery, Pharmacological Reviews, vol.61, issue.3, pp.283-357, 2009. ,
DOI : 10.1124/pr.109.001370
URL : https://hal.archives-ouvertes.fr/hal-02058111
The Role of CXCR7/RDC1 as a Chemokine Receptor for CXCL12/SDF-1 in Prostate Cancer, Journal of Biological Chemistry, vol.165, issue.7, pp.4283-4294, 2008. ,
DOI : 10.1074/jbc.M508234200
Malignant Tumors, The Journal of Clinical Endocrinology & Metabolism, vol.88, issue.6, pp.2579-2585, 2003. ,
DOI : 10.1210/jc.2002-021748
URL : https://hal.archives-ouvertes.fr/hal-01706414
Expression and Effect of Adrenomedullin in Pheochromocytoma, Annals of the New York Academy of Sciences, vol.42, issue.1, pp.270-276, 2006. ,
DOI : 10.1016/0014-5793(94)80106-1
Expression of neuropeptide hormone receptors in human adrenal tumors and cell lines: Antiproliferative effects of peptide analogues, Proceedings of the National Academy of Sciences, vol.31, issue.5, pp.15879-15884, 2009. ,
DOI : 10.1097/01.CCM.0000063282.83188.3D